BSEInsider Trading / SAST2d ago · 23 Sept 2026, 02:28 pm
Intimation of Closure of Trading Window.
Lincoln Pharmaceuticals Ltd · 531633
✦ AI SummaryResults
Lincoln Pharmaceuticals Ltd has announced the closure of its trading window from October 1, 2026, till 48 hours after the declaration of its financial results for the quarter ended September 30, 2026. The company has informed its directors, senior management personnel, promoters, and connected persons not to trade in its securities during this period.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Lincoln Pharmaceuticals Ltd - 531633 - Closure of Trading Window
Attachments (1)
📄pdf
Download →
98ee779d-109a-446f-86ef-ff82b7118dc0.pdf
View document text
LINCOLN
PHARMACEUTICALS LTD.
H�L THCARla FOR ALL
Date: September 23, 2026
To, To,
The Manager, Listing Department, The Department of Corporate Service,
National Stock Exchange of India Limited, BSE Limited,
Exchange Plaza, C – 1, Block – G, 1st Floor, New Trading Ring,
Bandra – Kurla Complex, Bandra (E), Rotunda Building, Phiroze Jeejeebhoy Tower,
Mumbai-400 051. Dalal Street, Mumbai – 400 001.
Scrip Code – LINCOLN Scrip Code – 531633
Dear Sir/Madam,
Sub: Intimation of Closure of Trading Window
We would like to inform that pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 and amendment thereto
("Regulations") and Code of Practices & Procedures for Fair Disclosure of Unpublished Price Sensitive Information adopted
by the Company, the Trading Window for dealing in the securities of the Company shall remain closed from October 01,
2026 till 48 hours after the declaration of the Financial Results of the Company, for the quarter ended September 30,
2026.
The date of meeting of the Board of Directors, to approve the Financial Results of the Company for the quarter ended
September 30, 2026, will be informed in due course.
Accordingly all Directors, Senior Management Personnel, Promoter and Promoter Group of the Company and its subsidiaries
including their Immediate Relatives and other Connected Persons are advised not to trade in securities of the Company
during the aforesaid period of closure of trading window.
We request you to kindly take the same on record.
Thanking you,
Yours faithfully,
FOR LINCOLN PHARMACEUTICALS LTD
TRUSHA K. SHAH
COMPANY SECRETARY &
COMPLIANCE OFFICER
Regd. Office: "Lincoln House", Science City Road, Sola, Ahmedabad-380 060. Gujarat, India "i®
Phone, +91-79-4107 8000 I Fax, +91-79-4107 8062 I CIN L24230GJ1995PLC024288
E-mail: info@lincolnpharma.com l Website: www.lincolnpharma.com
Factory: 10, 12, 13. Trimul Estate. Near Khatraj Chokadi, P.O. Khatraj-382721.
Ta.: Kalal, Dist. Gandhinagar, (Guj.) I Phone: +91-79-49135000 I E-mail: khatraj@lincolnpharma.com
.,,.
lntertek '"